Market Research Life Sciences Market Research Pharmaceuticals Market Research Therapeutic Area Market Research CNS/Neurology Market Research

Global Glioblastoma Market and Competitive Landscape – 2017

Best Price Guarantee Publisher Published Date SKU
from $3,990 Fore Pharma August, 2017 FPCI15450528
Best Price Guarantee
Price from $3,990
Publisher Fore Pharma
Published Date August, 2017
SKU FPCI15450528

Global Glioblastoma Market and Competitive Landscape – 2017

The latest research from Fore Pharma, Global Glioblastoma Market and Competitive Landscape – 2017, provides comprehensive insights into Glioblastoma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Glioblastoma market size and drug sales. This research also provides insights into Glioblastoma epidemiology and late stage pipeline.
The report is classified into twelve sections – Glioblastoma overview with definitions, symptoms, etiology, diagnosis, treatment options; Glioblastoma pipeline insights covering late stage clinical trials pipeline; Glioblastoma prevalence trends by countries; Glioblastoma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes G7 countries – US, Germany, France, Italy, Spain, UK, Japan, Europe, Global.

Research Scope:

  • Glioblastoma pipeline: Find out the drugs in clinical trials for Glioblastoma by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company
  • Glioblastoma epidemiology: Find out the prevalence of Glioblastoma by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; prevalence forecast to 2025
  • Glioblastoma products: Identify key products marketed and prescribed for Glioblastoma by brand name, by molecule, by company, by branded / generic, by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Glioblastoma market size: Find out the market size for Glioblastoma drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan; Find out how the market advanced from 2012
  • Glioblastoma drug sales: Find out the sales of Glioblastoma drugs by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan, Global
  • Glioblastoma drugs sales forecast: Sales forecast for Glioblastoma drugs to 2021 by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
  • Glioblastoma market share analysis: Find out the market shares of Glioblastoma drugs and outlook by countries – US, Europe, Germany, France, Italy, Spain, UK, Japan
Benefits of this Research: The research helps executives to
  • Evaluate commercial market opportunities for Glioblastoma drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in Glioblastoma market
  • Develop in-depth knowledge of competition and markets
  • Analyze sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track market trends and analyze key events in Glioblastoma market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies


1. Glioblastoma: Disease Overview
1.1. Glioblastoma Symptoms
1.2. Glioblastoma Etiology
1.3. Glioblastoma Diagnosis
1.4. Glioblastoma Treatment Options
2. Glioblastoma Pipeline Insights
2.1. Glioblastoma Phase 3 Clinical Trials
2.2. Glioblastoma Phase 2 Clinical Trials
2.3. Glioblastoma Phase 1 Clinical Trials
3. Glioblastoma Epidemiology Analysis
4. US Glioblastoma Market Insights
4.1. Marketed Products for Glioblastoma in US
4.2. US Glioblastoma Market Size & Forecast
4.3. US Glioblastoma Product Sales Forecast
4.4. US Glioblastoma Market Share Analysis
5. Germany Glioblastoma Market Insights
5.1. Marketed Products for Glioblastoma in Germany
5.2. Germany Glioblastoma Market Size & Forecast
5.3. Germany Glioblastoma Product Sales Forecast
5.4. Germany Glioblastoma Market Share Analysis
6. France Glioblastoma Market Insights
6.1. Marketed Products for Glioblastoma in France
6.2. France Glioblastoma Market Size & Forecast
6.3. France Glioblastoma Product Sales Forecast
6.4. France Glioblastoma Market Share Analysis
7. Italy Glioblastoma Market Insights
7.1. Marketed Products for Glioblastoma in Italy
7.2. Italy Glioblastoma Market Size & Forecast
7.3. Italy Glioblastoma Product Sales Forecast
7.4. Italy Glioblastoma Market Share Analysis
8. Spain Glioblastoma Market Insights
8.1. Marketed Products for Glioblastoma in Spain
8.2. Spain Glioblastoma Market Size & Forecast
8.3. Spain Glioblastoma Product Sales Forecast
8.4. Spain Glioblastoma Market Share Analysis
9. UK Glioblastoma Market Insights
9.1. Marketed Products for Glioblastoma in UK
9.2. UK Glioblastoma Market Size & Forecast
9.3. UK Glioblastoma Product Sales Forecast
9.4. UK Glioblastoma Market Share Analysis
10. Europe Glioblastoma Market Insights
10.1. Europe Glioblastoma Market Size & Forecast
10.2. Europe Glioblastoma Product Sales Forecast
10.3. Europe Glioblastoma Market Share Analysis
11. Japan Glioblastoma Market Insights
11.1. Marketed Products for Glioblastoma in Japan
11.2. Japan Glioblastoma Market Size & Forecast
11.3. Japan Glioblastoma Product Sales Forecast
11.4. Japan Glioblastoma Market Share Analysis
12. Global Glioblastoma Market Insights
12.1. Global Glioblastoma Market Size & Forecast
12.2. Global Glioblastoma Product Sales Forecast
12.3. Global Glioblastoma Market Share Analysis
13. Research Methodology
LIST OF TABLES
Table 1: Glioblastoma Phase 3 Clinical Trials, Global, 2017
Table 2: Glioblastoma Phase 2 Clinical Trials, Global, 2017
Table 3: Glioblastoma Phase 1 Clinical Trials, Global, 2017
Table 4: Glioblastoma Prevalence by G7 Countries, 2012 - 2021
Table 5: Marketed Products for Glioblastoma in US, 2017
Table 6: US Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 7: US Glioblastoma Product Sales ($mn), 2012 - 2021
Table 8: US Glioblastoma Market Trends, 2012 - 2021
Table 9: Marketed Products for Glioblastoma in Germany, 2017
Table 10: Germany Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 11: Germany Glioblastoma Product Sales ($mn), 2012 - 2021
Table 12: Germany Glioblastoma Market Trends, 2012 - 2021
Table 13: Marketed Products for Glioblastoma in France, 2017
Table 14: France Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 15: France Glioblastoma Product Sales ($mn), 2012 - 2021
Table 16: France Glioblastoma Market Trends, 2012 - 2021
Table 17: Marketed Products for Glioblastoma in Italy, 2017
Table 18: Italy Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 19: Italy Glioblastoma Product Sales ($mn), 2012 - 2021
Table 20: Italy Glioblastoma Market Trends, 2012 - 2021
Table 21: Marketed Products for Glioblastoma in Spain, 2017
Table 22: Spain Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 23: Spain Glioblastoma Product Sales ($mn), 2012 - 2021
Table 24: Spain Glioblastoma Market Trends, 2012 - 2021
Table 25: Marketed Products for Glioblastoma in UK, 2017
Table 26: UK Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 27: UK Glioblastoma Product Sales ($mn), 2012 - 2021
Table 28: UK Glioblastoma Market Trends, 2012 - 2021
Table 29: Europe Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 30: Europe Glioblastoma Product Sales ($mn), 2012 - 2021
Table 31: Marketed Products for Glioblastoma in Japan, 2017
Table 32: Japan Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 33: Japan Glioblastoma Product Sales ($mn), 2012 - 2021
Table 34: Japan Glioblastoma Market Trends, 2012 - 2021
Table 35: Global Glioblastoma Market Size & Forecast ($mn), 2012 - 2021
Table 36: Global Glioblastoma Product Sales ($mn), 2012 - 2021
LIST OF FIGURES
Figure 1: Glioblastoma Pipeline by Phase (%), Global, 2017
Figure 2: Glioblastoma Prevalence by G7 Countries, 2012 - 2021
Figure 3: US Glioblastoma Market Size ($mn), 2012 - 2021
Figure 4: US Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 5: US Glioblastoma Market Share by Products (%), 2016
Figure 6: US Glioblastoma Market - Future Market Share (%), 2021
Figure 7: Germany Glioblastoma Market Size ($mn), 2012 - 2021
Figure 8: Germany Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 9: Germany Glioblastoma Market Share by Products (%), 2016
Figure 10: Germany Glioblastoma Market - Future Market Share (%), 2021
Figure 11: France Glioblastoma Market Size ($mn), 2012 - 2021
Figure 12: France Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 13: France Glioblastoma Market Share by Products (%), 2016
Figure 14: France Glioblastoma Market - Future Market Share (%), 2021
Figure 15: Italy Glioblastoma Market Size ($mn), 2012 - 2021
Figure 16: Italy Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 17: Italy Glioblastoma Market Share by Products (%), 2016
Figure 18: Italy Glioblastoma Market - Future Market Share (%), 2021
Figure 19: Spain Glioblastoma Market Size ($mn), 2012 - 2021
Figure 20: Spain Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 21: Spain Glioblastoma Market Share by Products (%), 2016
Figure 22: Spain Glioblastoma Market - Future Market Share (%), 2021
Figure 23: UK Glioblastoma Market Size ($mn), 2012 - 2021
Figure 24: UK Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 25: UK Glioblastoma Market Share by Products (%), 2016
Figure 26: UK Glioblastoma Market - Future Market Share (%), 2021
Figure 27: Europe Glioblastoma Market Size ($mn), 2012 - 2021
Figure 28: Europe Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 29: Europe Glioblastoma Market Share by Products (%), 2016
Figure 30: Europe Glioblastoma Market - Future Market Share (%), 2021
Figure 31: Japan Glioblastoma Market Size ($mn), 2012 - 2021
Figure 32: Japan Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 33: Japan Glioblastoma Market Share by Products (%), 2016
Figure 34: Japan Glioblastoma Market - Future Market Share (%), 2021
Figure 35: Global Glioblastoma Market Size ($mn), 2012 - 2021
Figure 36: Global Glioblastoma Product Sales ($mn), 2012 - 2021
Figure 37: Global Glioblastoma Market Share by Products (%), 2016
Figure 38: Global Glioblastoma Market - Future Market Share (%), 2021

$3,990
$5,650

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings